Patents by Inventor Abraham G. EAPPEN

Abraham G. EAPPEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11883475
    Abstract: The application is directed to in vitro-reared Plasmodium sporozoites of human host range wherein sporogony from gametocyte stage to sporozoite stage is external to mosquitoes, and methods of producing the same. Provided herein are in vitro-reared infectious Plasmodium sporozoites (SPZ) of human host range, particularly P. falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi, wherein sporogony from gametocyte stage to sporozoite stage is external to mosquitoes, and methods of producing the same.
    Type: Grant
    Filed: November 18, 2021
    Date of Patent: January 30, 2024
    Assignee: Sanaria Inc.
    Inventors: Abraham G. Eappen, Stephen L Hoffman
  • Publication number: 20220257742
    Abstract: The application is directed to in vitro-reared Plasmodium sporozoites of human host range wherein sporogony from gametocyte stage to sporozoite stage is external to mosquitoes, and methods of producing the same. Provided herein are in vitro-reared infectious Plasmodium sporozoites (SPZ) of human host range, particularly P. falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi, wherein sporogony from gametocyte stage to sporozoite stage is external to mosquitoes, and methods of producing the same.
    Type: Application
    Filed: November 18, 2021
    Publication date: August 18, 2022
    Inventors: Abraham G. EAPPEN, Stephen L. HOFFMAN
  • Patent number: 11207395
    Abstract: The application is directed to in vitro-reared Plasmodium sporozoites of human host range wherein sporogony from gametocyte stage to sporozoite stage is external to mosquitoes, and methods of producing the same. Provided herein are in vitro-reared infectious Plasmodium sporozoites (SPZ) of human host range, particularly P. falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi, wherein sporogony from gametocyte stage to sporozoite stage is external to mosquitoes, and methods of producing the same.
    Type: Grant
    Filed: September 5, 2019
    Date of Patent: December 28, 2021
    Assignee: Sanaria Inc.
    Inventors: Abraham G. Eappen, Stephen L. Hoffman
  • Publication number: 20200113987
    Abstract: The application is directed to in vitro-reared Plasmodium sporozoites of human host range wherein sporogony from gametocyte stage to sporozoite stage is external to mosquitoes, and methods of producing the same. Provided herein are in vitro-reared infectious Plasmodium sporozoites (SPZ) of human host range, particularly P. falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi, wherein sporogony from gametocyte stage to sporozoite stage is external to mosquitoes, and methods of producing the same.
    Type: Application
    Filed: September 5, 2019
    Publication date: April 16, 2020
    Applicant: Sanaria Inc.
    Inventors: Abraham G. EAPPEN, Stephen L. HOFFMAN
  • Patent number: 10441646
    Abstract: The application is directed to in vitro-reared Plasmodium sporozoites of human host range wherein sporogony from gametocyte stage to sporozoite stage is external to mosquitoes, and methods of producing the same. Provided herein are in vitro-reared infectious Plasmodium sporozoites (SPZ) of human host range, particularly P. falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi, wherein sporogony from gametocyte stage to sporozoite stage is external to mosquitoes, and methods of producing the same.
    Type: Grant
    Filed: December 29, 2017
    Date of Patent: October 15, 2019
    Assignee: Sanaria Inc.
    Inventors: Abraham G. Eappen, Stephen L. Hoffman
  • Publication number: 20180161413
    Abstract: The application is directed to in vitro-reared Plasmodium sporozoites of human host range wherein sporogony from gametocyte stage to sporozoite stage is external to mosquitoes, and methods of producing the same. Provided herein are in vitro-reared infectious Plasmodium sporozoites (SPZ) of human host range, particularly P. falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi, wherein sporogony from gametocyte stage to sporozoite stage is external to mosquitoes, and methods of producing the same.
    Type: Application
    Filed: December 29, 2017
    Publication date: June 14, 2018
    Applicant: SANARIA INC.
    Inventors: Abraham G. EAPPEN, Stephen L. HOFFMAN
  • Patent number: 9878026
    Abstract: The application is directed to in-vitro-reared Plasmodium sporozoites of human host range wherein sporogony from gametocyte stage to sporozoite stage is external to mosquitoes, and methods of producing the same. Provided herein are in vitro-reared infectious Plasmodium sporozoites (SPZ) of human host range, particularly P. falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi, wherein sporogony from gametocyte stage to sporozoite stage is external to mosquitoes, and methods of producing the same.
    Type: Grant
    Filed: April 11, 2016
    Date of Patent: January 30, 2018
    Assignee: SANARIA INC.
    Inventors: Abraham G. Eappen, Stephen L. Hoffman
  • Publication number: 20160287688
    Abstract: The application is directed to in vitro-reared Plasmodium sporozoites of human host range wherein sporogony from gametocyte stage to sporozoite stage is external to mosquitoes, and methods of producing the same. Provided herein are in vitro-reared infectious Plasmodium sporozoites (SPZ) of human host range, particularly P. falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi, wherein sporogony from gametocyte stage to sporozoite stage is external to mosquitoes, and methods of producing the same.
    Type: Application
    Filed: April 11, 2016
    Publication date: October 6, 2016
    Applicant: SANARIA INC.
    Inventors: Abraham G. EAPPEN, Stephen L. HOFFMAN